Shankara,Cold Storage Plant |
Giridhar K.,NSSO |
Thandapani M.,NSSO |
Biram Saheb N.M.,SSPC
Indian Silk | Year: 2010
Scientific method of preservation, proper stock maintenance, timely release and supply of disease free layings in well-organized manner play a vital role in the sustenance and growth of the silk industry, particularly in bivoltine seed sector. The software has been developed during 2005 using MS-Access 2000 with Windows Operating System. A Pentium-Ill Computer, 128 MB RAM with Windows-98 Pentium IV Computer with Windows-2000, Windows-Millennium or Windows XP and MS-Access 2000 version or above is sufficient to run the software. This software has been tested thoroughly for over six years for its efficiency and accuracy with large volume of data received from the units. The user can obtain supply reports/data of individual center with particular receipt number. Any problem with any lot, issued among different sericulturists during a particular period, can easily be analyzed and feedback can be generated with this menu.
Beggs A.,SSPC |
Journal of Protective Coatings and Linings | Year: 2012
SSPC-PA 17 was developed to provide specifiers, inspectors, and contractors with a standard set of acceptance criteria to determine compliance with steel profile requirements in industry project specifications. In many ways it is similar to the SSPC-PA 2 standard, which has been widely specified since its initial publication in 1996. As with all SSPC standards, PA 17 is subject to periodic reapproval or revision at least every five years. Revisions may be made within that period if the committee agrees that they are necessary. The committee anticipates that refinements will be proposed as the PA 17 standard becomes more generally specified and used, and welcomes suggestions to improve the usefulness and clarity of this, and all other SSPC standards.
News Article | October 5, 2009
Some unexpected bad news out of Seattle Genetics is driving down its stock 14 percent this morning. The Bothell, WA-based developer of antibody drugs for cancer (NASDAQ: SGEN) said a mid-stage clinical trial of an experimental lymphoma drug was halted midway through enrollment after an independent panel of data monitors determined the experimental drug was unlikely to reach its goal of beating the control group. The Seattle Genetics antibody drug, called dacetuzumab or SGN-40, was being studied in a trial of 224 patients with diffuse large B-cell lymphoma, in combination with rituximab (Rituxan) and standard chemotherapies. Patients in the control group got the same treatment, except a placebo instead of the Seattle Genetics drug. About two-thirds of the patients were enrolled in the randomized, blinded trial before it was closed. Seattle Genetics didn’t say anything in its statement today about the safety profile of its drug. The trial failure is a setback for Seattle Genetics, which has been developing this drug since January 2007 in partnership with Genentech and now Roche. The new antibody is designed to hit a different target found on cells, called CD40, which is found on many types of malignant B cells and is supposed to be complementary to the standard rituximab antibody that hits another target called CD20. Rituximab, the pioneering antibody for cancer, generated $2.59 billion in U.S. sales last year as it has become a standard lymphoma treatment. Yet as good as it is, patients eventually see their disease spread, and relapse after getting rituximab. Seattle Genetics pointed out in its release that it has four other smaller clinical trials of its dacetuzumab treatment for non-Hodgkin’s lymphoma and multiple myeloma, a cancer of the bone marrow. “We are disappointed that the interim analysis of the phase IIb clinical trial resulted in discontinuation of the study, especially given the unmet medical need for DLBCL patients,” said Clay Siegall, CEO of Seattle Genetics, in a statement. “In collaboration with Genentech, we will conduct a detailed analysis of data from the SeaGen MARINER trial.” Seattle Genetics shares fell $1.79, or about 14 percent, at the opening bell this morning to $11.83.
Abstract: Tesla NanoCoatings, the world leader in nanotechnology for corrosion protection, announced a significant addition to its team. Joseph Davis has joined as vice president-sales engineering. Davis is recognized throughout the industry as an authority on corrosion prevention and protection. He maintains certifications as a NACE Level III certified inspector as well as SSPC C1 and C2, and a Protective Coatings Specialist. Davis serves as the chairman of the AWWA D102 Coating of Steel Water Tank Committee and as chairman of the NACE International Institute's NIICAP Oversight Board. He most recently served as vice president of the technical service group for TNEMEC Company Inc., in Kansas City, Mo., where he helped establish the company's strategic vision, and coordinated the efforts of the technical service department, analytical lab, and panel sample lab, with the marketing and research and development groups. "As we continue to lead innovation in corrosion-fighting technology to meet our global customer base's demands for corrosion protection, Joe brings a wealth of coatings-industry technical experience to our team," said Tesla NanoCoatings President Todd Hawkins. "Joe is playing an integral role in educating customers about our breakthrough 2X1 Wet Edge technology, our two-coat epoxy primer and topcoat system that replaces conventional three-coat systems traditionally used to protect steel surfaces in any environment in all corners of the globe, offering significant advantages not only in corrosion protection, but also in application time and effort." Davis' prior work experience also includes president of DavCorr Corrosion Services, CEO of DavCorr Inc, and industrial specification specialist for ICI-Devoe High Performance Coatings. About Tesla NanoCoatings Tesla NanoCoatings, Inc. (www.teslanano.com) is a technology company based in Massillon, Ohio. The company's product line is Teslan®, a highly effective corrosion control coating for structural steel utilizing carbon nanotechnology, to create innovative solutions to corrosion issues. For more information, please click If you have a comment, please us. Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Mohanan N.M.,SSPC |
Daniel J.,SSPC |
Gopalakrishnan P.,SSPC |
John J.N.,Cluster Development Center |
Mohandas T.P.,Cluster Development Center
Indian Silk | Year: 2010
Attapaddy in Kerala is a potential area for generation of bivoltine seed cocoons. It is a rain shadow area of Palakkad district with about 450-500m altitude above mean sea level. Performance of P1 seed crop rearing and cocoons from Attappady was evaluated for the years 2006-07, 2007-08 and 2008-09. During 2006-07, P1 seed was distributed among 6 seed rearers adopted as per the ISO norms and during 2007-08 and 2008-09, it was distributed to 7 and 17 farmers, respectively. Data on crop success, cocoon yield, pupation, dfls produced and egg recovery were recorded and studied. During the study period, the highest number of P1 seed was brushed during 2008-09 followed by 2007-08 and 2006-07 while crop success was highest during 2007-08 and least during 2006-07. Performance of seed crop rearing and the grainage performance of seed cocoons generated from Attappady for the three years, indicate a continuous improvement both in quantity and quality.